Skip to content

Clinical trials

Myelodysplastic Syndromes trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Country / region: Australia Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20052
20061
20073
20105
20112
20132
20144
20155
20162
20175
20183
20192
20207
20215
20228
20237
20243
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Terminated13
Recruiting12
Active, not recruiting11
Withdrawn2
Unknown status2
Enrolling by invitation1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals9
Celgene7
Children's Oncology Group7
AbbVie4
Takeda4
Bristol-Myers Squibb3
Institut de Recherches Internationales Servier3
Janssen Research & Development, LLC3
Otsuka Australia Pharmaceutical Pty Ltd2
Peter MacCallum Cancer Centre, Australia2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes76
Leukemia, Myeloid, Acute34
Leukemia, Myelomonocytic, Chronic16
Anemia10
Leukemia10
Myeloproliferative Disorders8
Precursor Cell Lymphoblastic Leukemia-Lymphoma8
Anemia, Refractory, with Excess of Blasts7
Lymphoma, Non-Hodgkin4
Multiple Myeloma4

Trials

Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.